BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16679390)

  • 1. Selective metabolism of vincristine in vitro by CYP3A5.
    Dennison JB; Kulanthaivel P; Barbuch RJ; Renbarger JL; Ehlhardt WJ; Hall SD
    Drug Metab Dispos; 2006 Aug; 34(8):1317-27. PubMed ID: 16679390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes.
    Dennison JB; Mohutsky MA; Barbuch RJ; Wrighton SA; Hall SD
    J Pharmacol Exp Ther; 2008 Oct; 327(1):248-57. PubMed ID: 18650247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.
    Dennison JB; Jones DR; Renbarger JL; Hall SD
    J Pharmacol Exp Ther; 2007 May; 321(2):553-63. PubMed ID: 17272675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A.
    Liu KH; Kim MG; Lee DJ; Yoon YJ; Kim MJ; Shon JH; Choi CS; Choi YK; Desta Z; Shin JG
    Drug Metab Dispos; 2006 Nov; 34(11):1793-7. PubMed ID: 16896065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes.
    Klees TM; Sheffels P; Dale O; Kharasch ED
    Drug Metab Dispos; 2005 Mar; 33(3):303-11. PubMed ID: 15557344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
    Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
    Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.
    Dai Y; Hebert MF; Isoherranen N; Davis CL; Marsh C; Shen DD; Thummel KE
    Drug Metab Dispos; 2006 May; 34(5):836-47. PubMed ID: 16501005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.
    Topletz AR; Dennison JB; Barbuch RJ; Hadden CE; Hall SD; Renbarger JL
    Drug Metab Dispos; 2013 Sep; 41(9):1651-61. PubMed ID: 23780963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
    Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
    Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a less toxic vinca alkaloid derivative for use as a chemotherapeutic agent, based on in silico structural insights and metabolic interactions with CYP3A4 and CYP3A5.
    Saba N; Seal A
    J Mol Model; 2018 Mar; 24(4):82. PubMed ID: 29502215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5.
    Bakken GV; Rudberg I; Christensen H; Molden E; Refsum H; Hermann M
    Drug Metab Dispos; 2009 Feb; 37(2):254-8. PubMed ID: 19022943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cytochrome P450 3A5*3 genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects.
    Kim KA; Park PW; Park JY
    Chirality; 2009 May; 21(5):485-91. PubMed ID: 18752284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach.
    Moore AS; Norris R; Price G; Nguyen T; Ni M; George R; van Breda K; Duley J; Charles B; Pinkerton R
    J Paediatr Child Health; 2011 Dec; 47(12):875-82. PubMed ID: 21658147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation.
    Isoherranen N; Ludington SR; Givens RC; Lamba JK; Pusek SN; Dees EC; Blough DK; Iwanaga K; Hawke RL; Schuetz EG; Watkins PB; Thummel KE; Paine MF
    Drug Metab Dispos; 2008 Jan; 36(1):146-54. PubMed ID: 17954524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.
    Egbelakin A; Ferguson MJ; MacGill EA; Lehmann AS; Topletz AR; Quinney SK; Li L; McCammack KC; Hall SD; Renbarger JL
    Pediatr Blood Cancer; 2011 Mar; 56(3):361-7. PubMed ID: 21225912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes.
    Wang MZ; Wu JQ; Dennison JB; Bridges AS; Hall SD; Kornbluth S; Tidwell RR; Smith PC; Voyksner RD; Paine MF; Hall JE
    Proteomics; 2008 Oct; 8(20):4186-96. PubMed ID: 18792928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
    Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism.
    McGraw J; Cherney M; Bichler K; Gerhardt A; Nauman M
    Toxicol Lett; 2019 Oct; 315():9-13. PubMed ID: 31408697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance.
    Yao D; Ding S; Burchell B; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 2000 Jul; 294(1):387-95. PubMed ID: 10871337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.